Article

An embryonic-specific repressor element located 3' to the Agamma-globin gene influences transcription of the human beta-globin locus in transgenic mice.

Department of Basic Sciences, University of Crete School of Medicine, Heraklion, Greece.
Experimental Hematology (Impact Factor: 2.81). 03/2004; 32(2):224-33. DOI: 10.1016/j.exphem.2003.11.001
Source: PubMed

ABSTRACT Persistent expression of the human fetal gamma-globin genes in the adult stage is often associated with naturally occurring deletions in the human beta-globin locus. The mapping of the 5' breakpoints of these deletions within the Agamma- to delta-globin intergenic region has suggested that regulatory elements involved in the silencing of the gamma-globin genes in the adult may be present. We previously identified two elements in this region, termed Enh and F, located 3' to the Agamma-globin gene acting as silencers in transient transfection assays. Here, we tested directly the in vivo significance of these elements in the developmental regulation of the human beta-like globin genes. MATERIALS AND METHODS. We selectively deleted both Enh and F elements in the context of a 185-kb human beta-globin locus PAC (P1 phage artificial chromosome) and tested the effects of this deletion on the expression of the human P-like globin genes in transgenic mice.
The Enh/F deletion resulted in an increase in epsilon- and gamma-globin mRNA levels in the embryonic yolk sac stage of erythropoiesis, which appears to be due to an increase in the rate of transcription rather than to an increase in the number of cells transcribing the human globin locus. However, the human developmental switching from fetal gamma-globin to adult beta-globin gene expression in transgenic mice was not affected by this deletion.
These results identify Enh and F as locus-wide regulatory elements capable of down-regulating transcription of the human beta-globin locus in an embryonic-specific manner.

0 Followers
 · 
86 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The human body consists of a huge number of cells. At the base of all these cells is one fertilized oocyte. By cell divisions the number of cells is increased during development, and cells specialize into various types of cells, i.e. muscle, brain and blood cells. Groups of specialized cells form the various tissues. DNA contains the blueprint of all cells. By each cell division the DNA is duplicated and equally distributed over the two daughter cells. Hence, practically all the cells contain identical genetic information. The DNA in each cell contains about 25.000 genes. Each gene contains information necessary to produce a particular protein. These proteins are involved in many processes such as energy metabolism, cell composition and gene regulation. Although all cells contain the same genetic information, they specialize into various cell types. For this, the genes are specifically activated or repressed. A tight regulation of the genes makes it possible to specialize into a particular type of cell. Transcription factors play an important role in this tight regulation of activating or repressing genes. EKLF is such a transcription factor. EKLF is mainly expressed in red blood cells. These cells give blood its red color. They carry oxygen from lungs to tissues in the body that require the oxygen for energy metabolism. Red blood cells are filled with hemoglobin that actually binds the oxygen. Each hemoglobin particle consists of two a-globin, two ß-globin and four heme molecules. The genetic blueprint for the ß-globin gene is called the ß-globin locus. In the mouse, this locus contains four globin genes. Two of them, the embryonic ß-globin genes, are active during embryonic development of the mice and the other two, the adult ß-globin genes are activated later in development and stay active during the rest of the lifespan of the mouse. Apart from the four ß-globin genes, the locus contains regulatory elements. These include the Locus Control Region (LCR), and a number of other hypersensitive sites. The LCR is required for a proper regulation of the globin genes; in absence of the LCR the genes are not activated, and mutations in the LCR can lead to impaired activation. The LCR is located relatively far from the genes it controls. However, when a globin gene is active in red blood cells, the LCR is physically in close proximity to this gene. In fact, the globin locus forms a spatial organization that consists not only of the active gene and the LCR, but also of the other hypersensitive sites that are located even further away on both sides of the genes. This structure is called the Active Chromatin Hub (ACH). Prior to the stage in which the genes are active, a substructure of this ACH is formed. Unlike the complete ACH, this substructure does not contain the globin genes and part of the LCR. In Chapter 4 we show that a similar substructure is found in red blood cells that are EKLF deficient. We demonstrated that EKLF is necessary for the completion of the ACH, a requirement for activating the genes. The transcription factor EKLF is necessary for the proper development of red blood cells; apart from the regulation of the ß-globin genes it regulates also other genes. However, it was not known which other genes. To study the genes EKLF activates (or represses), we used a culture method with erythroid progenitor cells. These progenitor cells are restricted to the red blood cell lineage, but have not yet developed to fully differentiated, hemoglobin- containing red blood cells. The culture method allows us to culture the cells as progenitors or induce them to start their terminal differentiation to red blood cells.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Natural deletions of the human gamma-globin gene cluster lead to specific syndromes characterized by increased production of fetal hemoglobin in adult life and provide a useful model to delineate novel cis-acting elements involved in the developmental control of hemoglobin switching. A hypothesis accounting for these phenotypic features assumes that silencers located within the Agamma-to delta-gene region are deleted in hereditary persistence of fetal hemoglobin (HPFH) and deltabeta-thalassemias, leading to failure of switching. In the present study, we sought to clarify the in vivo role of two elements, termed Enh and F, located 3' to the Agamma-globin, in silencing the fetal genes. To this end, we generated three transgenic lines using cosmid constructs containing the full length of the globin locus control region (LCR) linked to the 3.3-kb Agamma-gene lacking both the Enh and F elements. The Enh/F deletion resulted in high levels of Agamma-globin gene expression in adult mice in all single copy lines, whereas, the LCR-Agamma single copy lines which retain the Enh and F elements exhibited complete normal switching of the fetal Agamma-gene. Our study documents directly for the first time the in vivo role of these two gene-proximal negative regulatory elements in silencing the fetal globin gene in the perinatal period, and thus these data may permit their eventual exploitation in therapeutic approaches for thalassemias.
    Molecular Medicine 09/2009; 15(11-12):415-24. DOI:10.2119/molmed.2009.00019 · 4.82 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: STAT5 controls essential cellular functions and is encoded by two genes, Stat5a and Stat5b. To provide insight to the mechanisms linking hematologic malignancy to STAT5 activation/regulation of target genes, we identified STAT5 target genes and focused on Dpf3 gene, which encodes for an epigenetic factor. Dpf3 expression was induced upon IL-3 stimulation in Ba/F3 cells, while strong binding of both STAT5a and STAT5b was detected in its promoter. Reduced expression of Dpf3 was detected in Ba/F3 cells with Stat5a and Stat5b knock-down, suggesting that this gene is positively regulated by STAT5, upon IL-3 stimulation. Furthermore, this gene was significantly up-regulated in CLL patients, where DPF3 gene/protein up-regulation and strong STAT5 binding to the DPF3 promoter, correlated with increased STAT5 activation, mainly in non-malignant myeloid cells (granulocytes). Our findings provide insights in the STAT5 dependent transcriptional regulation of Dpf3, and demonstrate for the first time increased STAT5 activation in granulocytes of CLL patients. Novel routes of investigation are opened to facilitate the understanding of the role of STAT5 activation in the communication between non-malignant myeloid and malignant B-cells, and the functions of STAT5 target genes networks in CLL biology.
    PLoS ONE 10/2013; 8(10):e76155. DOI:10.1371/journal.pone.0076155 · 3.53 Impact Factor

Full-text

Download
19 Downloads
Available from
May 27, 2014